760
Participants
Start Date
March 31, 2005
Primary Completion Date
October 31, 2009
Study Completion Date
March 31, 2011
Flecainide
Flecainide 2 - 3 x 100 mg/d The main difference between the two active therapy groups is the duration of treatment.
Collaborators (2)
German Federal Ministry of Education and Research
OTHER_GOV
Meda Pharmaceuticals
INDUSTRY
German Research Foundation
OTHER
Atrial Fibrillation Network
OTHER